glp-1 obesity drug news today september 15 2025 anti-obesity drugs lead to substantial weight loss in the “real world” Alarming rise in weight loss
Description
Barrea L, Verde L, Camajani E, Cernea S, Frias-Toral E, Lamabadusuriya D et al (2023) Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS)
Three nonrandomized studies showed a higher incidence of elevated RGC content in 1011 patients who used GLP-1RAs ( OR 6.08
10.34172/mejdd.2022.278 54 SchmidtH
Obesity (2022)
We prioritize patient safety and personalized care
For example, efpeglenatide, a long-acting GLP-1 RA and an exendin analog linked to an IgG4 Fc fragment, has been explored for once-monthly administration to treat type 2 diabetes
